Bacardi Hosts Evening Of Art And Fashion Honoring Celia Cruz

Bacardi Women in Leadership reveals tickets are now on sale for its Evening of Art & Fashion on Saturday, October 6, at the American Museum of the Cuban Diaspora.  This twilight cocktail affair is the opening celebration for the 25th anniversary of Dress for Success Miami, which nurtures a nexus of support, professional attire, and success tools to help women shine in work and in life.  Guests will be the first to preview 'Forever Celia' – the greatest show ever created highlighting an intimate and immersive look at the life of the fabulous Queen of Salsa.
   
'We are excited to kick off our 25th anniversary year with this unique celebration of women,' says Sonia Jacobson, founder and executive director of Suited for Success/Dress for Success Miami.  'We are so grateful to the Miami community for helping us reach this milestone, and to partners like Bacardi who make it possible for us to continue empowering women across Miami-Dade County.'
   
VIP guests will treat their senses in a private cognac, whiskey and cigar lounge hosted by Bacardi and catch an exclusive fashion show presenting a Rene by RR collection from famous Cuban fashion designer Rene Ruiz.  Patrons will converge on the museum's rooftop terrace for live music and to flash on a live mural painting by Ecuadorian artist Alejandra Estefania.
   
'As we've been bringing people together for more than 156 years, Bacardi is proud to partner with organizations like Dress for Success Miami, that celebrates and empowers women to be the best version of themselves', said Paula Glickenhaus, VP & global head of Women in Leadership for Bacardi.  'Bacardi Women in Leadership jumped at the opportunity to host an event that combines art and fashion, celebrates the spirit of a powerful female music icon, and reinforces our long-standing legacy and commitment to community involvement and philanthropy.'

Comments

Post a Comment

Popular posts from this blog

Pepsi Buys Rockstar

Pepsi buys Rockstar .     P epsiCo buys Rockstar Energy Beverages for $3.85 billion.     Founded in 2001, Rockstar is drinks designed for people leading an active lifestyle. Available in 20 flavors at convenience and grocery stores in 30 countries. Distributed by PepsiCo in North America since 2009. Supporting the Rockstar lifestyle across the globe through action sports, motorsports, and live music. Pepsi's energy portfolio also includes Kickstart , GameFuel, and Amp Energy.     The deal reflects the shift from reliance on sales of sugary, fizzy drinks toward options ranging from tea and coffee to still and sparkling water varieties, which appeal to health-conscious and younger consumers. Neither PepsiCo nor Coca-Cola owns a major brand in the energy drinks category, which is forecast to grow to more than $80 billion over the next five years and is now dominated by Red Bull.     2 00 countries and territories around the world enjoy ...
Read more

Compass Buys Marucci

Compass buys Marucci.     Compass Diversified Holdings buys Marucci Sports for $200 million.     Marucci Sports was founded in 2009 by Kurt Ainsworth, a retired pitcher for the San Francisco Giants and Baltimore Orioles, Joe Lawrence, a former second baseman for the Toronto Blue Jays, and Reed Dickens, a former White House Assistant Press Secretary under George W. Bush.     Marucci ’s first buy was Marucci Bat Company, launched out of a backyard shed in 2004. Ainsworth then led the buyout of an Amish-run Pennsylvania wood mill in 2008. This solidified Marucci's superior wood supply, and it still supplies all Marucci's wood today. In 2017 Marucci bought Victus , a baseball equipment maker known for its edgy designs and big attitude.     With vertically cohesive wood bat production, a global supplier group, and a client base of MVPs and World Series winners, Marucci and Victus are the top two bats among Big League players. T...
Read more

Gilead Buys Forty Seven

Gilead buys Forty Seven.     Gilead Sciences buys Forty Seven for $4.9 billion.     Forty Seven is a clinical-stage immuno-oncology firm developing therapies targeting cancer immune evasion pathways and specific cell targeting approaches based on tech licensed from Stanford. Forty Seven’s lead program, magrolimab , is a monoclonal antibody against the CD47 receptor, a ‘don’t eat me’ signal that cancer cells commandeer to avoid being ingested by macrophages. Evaluated ant ibodies are in many clinical studies of patients with myelodysplastic syndrome, acute myeloid leukemia, non-Hodgkin lymphoma, and solid tumors. These assets complement the cell therapy franchise Gilead added with its 2017 buy of Kite Pharma .     Beyond magrolimab , Forty Seven is fixing to advance two more compounds into clinical testing. Developing FSI-174, an anti-cKIT antibody, in combination with magrolimab creates a novel, all-antibody conditioning regimen to address ...
Read more